Cite Filings / NVCT / 0001104659-22-012184
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B4

Prospectus

Nuvectis Pharma, Inc. · Filed 2022-02-07 · Acc 0001104659-22-012184

Documents 1

  • 424B4 Prospectus , tm2134024-11_424b4.htm

Around this filing

  • 2022-02-08 4 Chief Science & Business Off bought 4,600 shares at an average $3.44 ($15,834)
  • 2022-02-08 4 Chief Development Officer bought 2,946 shares at an average $3.41 ($10,034)
  • 2022-02-08 4 Chairman & CEO bought 232,500 shares at an average $4.96 ($1,153,145)
  • 2022-02-08 3 Initial Statement of Ownership
  • 2022-02-08 3 Initial Statement of Ownership
  • 2022-02-08 3 Initial Statement of Ownership
  • 2022-02-07 424B4 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2134024-11_424b4.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…